Reze, France

Richard Danger

This inventor holds 6 USPTO granted patents and 2 published patent applications and 5 EPO patents. Top assignees: Centre Hospitalier Universitaire De Nantes, National Institute of Health and Medical Research, The University of Nantes. Active years: 2021-2024.

USPTO Granted Patents = 6 

% Patents Active = 83.3

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Nantes, FR (2021 - 2022)
  • Rezé, FR (2021 - 2023)
  • Reze, FR (2022 - 2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Richard Danger - Pioneering Inventor from Rezé, France

Introduction: Richard Danger is a renowned inventor hailing from Rezé, France, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Richard Danger holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: Throughout his illustrious career, Richard Danger has consistently pushed the boundaries of innovation, with his inventions revolutionizing industries and improving the quality of life for many around the world. His dedication to creating impactful solutions has earned him recognition as a visionary inventor.

Collaborations: Richard Danger has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his inventions. His collaborative efforts have led to the successful implementation of innovative technologies in diverse sectors.

Conclusion: Richard Danger's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the global technological landscape, inspiring future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…